CRN Denounces FDA Rejection of NDI Notifications for Hemp Extract Containing CBD

The Council for Responsible Nutrition (CRN) has denounced the U.S. Food and Drug Administration’s (FDA) rejection of two new dietary ingredient (NDI) notifications for full-spectrum hemp extract containing cannabidiol (CBD)—and urged Congress to act on pending legislative proposals that require the agency to address the lack of regulation of hemp-derived products. “CRN is extremely disappointed to ...